Trends in Immunology
Volume 34, Issue 9, September 2013, Pages 440-445
Journal home page for Trends in Immunology

Review
Inflammatory dendritic cells in mice and humans

https://doi.org/10.1016/j.it.2013.06.001Get rights and content

Highlights

  • InfDCs are a distinct subset of DCs that appear during inflammation.

  • InfDCs derive from monocytes that differentiate in situ at the site of inflammation.

  • InfDCs can migrate to the lymph nodes and activate CD4+ and CD8+ T cells.

  • Human equivalents of infDCs have been identified in several inflammatory diseases.

Dendritic cells (DCs) are a heterogeneous population of professional antigen-presenting cells. Several murine DC subsets have been identified that differ in their phenotype and functional properties. In the steady state, DC precursors originating from the bone marrow give rise to lymphoid-organ-resident DCs and to migratory tissue DCs. During inflammation, an additional DC subset has been described, so-called inflammatory DCs (infDCs), which differentiate from monocytes recruited to the site of inflammation. Here, we review recent work on the development and functions of murine infDCs. We also examine the criteria that define infDCs. Finally, we discuss the characterization of human infDCs and their potential role in inflammatory diseases.

Section snippets

Overview of DC subsets

DCs are a heterogeneous population comprising several subsets that can be separated based on phenotypic markers. Murine steady-state DC subsets can be classified into two main categories: plasmacytoid DCs (pDCs) and classical DCs (cDCs). cDCs derive from a common precommitted precursor, the pre-cDC, that is dependent on Fms-like tyrosine kinase 3-ligand (Flt3L) [1], and they share key functional properties, such as constitutive expression of MHC class II molecules, ability to process antigens

Definition of infDCs

In mice, infDCs were initially identified as MHC II+ CD11b+ CD11c+ F4/80+ Ly6C+ DCs that are absent from steady-state tissues and lymphoid organs, and differentiate from monocytes during inflammation [8]. InfDCs have since been described during pathogenic inflammation (cutaneous Leishmania major infection 8, 9, systemic Listeria monocytogenes infection 10, 11, 12, systemic Trypanosoma brucei infection 13, 14, fungal infections 15, 16, 17, genital herpes simplex virus (HSV)-2 infection [18],

Development of infDCs

InfDCs were initially described to differentiate in situ from monocytes recruited to the sites of inflammation [8]. Several lines of evidence support a precursor–product relation between monocytes and infDCs. In vivo transfer experiments have shown that injected monocytes differentiate into infDCs in different inflammation models 8, 12, 13, 15, 23, 24, 29, 30, 31, 39. A similar conclusion was drawn using a reporter mouse expressing fluorescent CCR2 (a chemokine receptor expressed by monocytes

infDCs and T cell activation

Several studies demonstrated that infDCs can present antigens to CD4+ T cells. InfDCs purified from lymphoid organs 8, 15, 19, 26, 27, 28, 29 or tissues [18] can activate antigen-specific CD4+ T cells ex vivo. Indirect evidence also suggests that infDCs can activate CD4+ T cells in vivo in peripheral tissues [44]. In addition, CD4+ T cell activation in vivo is abrogated during A. fumigatus infection in mice depleted of CCR2+ cells [15] and strongly decreased in CCR2-deficient but not in

Human infDCs

In humans, several DC subsets have also been identified, including lymphoid-organ-resident and migratory DCs. infDCs have been described in several pathological inflammatory situations: atopic dermatitis, psoriasis, rheumatoid arthritis, and tumor ascites. Inflammatory dendritic epidermal cells (IDECs) were first described in the skin of atopic dermatitis patients [45]. These cells express surface markers different from Langerhans cells and dermal DCs from healthy skin. Recently, we identified

Concluding remarks

InfDCs are a distinct subset of DCs that appear during inflammation and derive from monocytes that differentiate in situ at the site of inflammation. InfDCs can migrate to the draining lymph nodes and activate CD4+ and CD8+ T cells. InfDCs have also been shown to stimulate effector or memory T cells directly in the inflamed tissue. Human equivalents of infDCs have been identified in several inflammatory diseases and in tumor ascites.

Although recent work provides insight into the development and

Acknowledgments

Our work is supported by INSERM, European Research Council (2008-AdG n°233062 PhagoDC) and Ligue contre le Cancer. The authors have no competing financial interests.

References (61)

  • C. Varol

    Intestinal lamina propria dendritic cell subsets have different origin and functions

    Immunity

    (2009)
  • A. Wollenberg

    Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema

    J. Invest. Dermatol.

    (1996)
  • E. Segura

    Human inflammatory dendritic cells induce Th17 cell differentiation

    Immunity

    (2013)
  • L.C. Zaba

    Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells

    J. Invest. Dermatol.

    (2009)
  • J. Cros

    Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors

    Immunity

    (2010)
  • J. Fuentes-Duculan

    A subpopulation of CD163-positive macrophages is classically activated in psoriasis

    J. Invest. Dermatol.

    (2010)
  • A. Wollenberg

    Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases

    J. Invest. Dermatol.

    (2002)
  • E. Guttman-Yassky

    Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis

    J. Allergy Clin. Immunol.

    (2007)
  • N. Novak

    FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro

    J. Allergy Clin. Immunol.

    (2004)
  • N.V. Serbina

    TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection

    Immunity

    (2003)
  • C. Cheong

    Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209+ dendritic cells for immune T cell areas

    Cell

    (2010)
  • K. Sere

    Two distinct types of Langerhans cells populate the skin during steady state and inflammation

    Immunity

    (2012)
  • C. Waskow

    The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues

    Nat. Immunol.

    (2008)
  • R.M. Steinman et al.

    Features of the dendritic cell lineage

    Immunol. Rev.

    (2010)
  • J.C. Miller

    Deciphering the transcriptional network of the dendritic cell lineage

    Nat. Immunol.

    (2012)
  • F. Ginhoux

    The origin and development of nonlymphoid tissue CD103+ DCs

    J. Exp. Med.

    (2009)
  • B.T. Edelson

    Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells

    J. Exp. Med.

    (2010)
  • G.J. Randolph

    Migration of dendritic cell subsets and their precursors

    Annu. Rev. Immunol.

    (2008)
  • R. Medzhitov

    Origin and physiological roles of inflammation

    Nature

    (2008)
  • C. De Trez

    iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice

    PLoS Pathog.

    (2009)
  • Cited by (0)

    View full text